Mineralys Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for MLYS

Based on 1 analyst offering 12 month price targets for Mineralys Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell MLYS stock?

Based on 1 analyst offering ratings for Mineralys Therapeutics Inc.
Strong Buy
0 analysts 0%
1 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MLYS stock forecasts and price targets.

MLYS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Credit Suisse
Bottom 12%

1 of 1

MLYS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AUTL$2.18$7.33+236.38%Strong Buy

Mineralys Therapeutics Stock Forecast FAQ

Is Mineralys Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MLYS) stock is to Buy MLYS stock.

Out of 1 analyst, 0 (0%) are recommending MLYS as a Strong Buy, 1 (100%) are recommending MLYS as a Buy, 0 (0%) are recommending MLYS as a Hold, 0 (0%) are recommending MLYS as a Sell, and 0 (0%) are recommending MLYS as a Strong Sell.

If you're new to stock investing, here's how to buy Mineralys Therapeutics stock.

What is MLYS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MLYS price target, the average MLYS price target is $37.00, with the highest MLYS stock price forecast at $37.00 and the lowest MLYS stock price forecast at $37.00.

The Wall Street analyst predicted that Mineralys Therapeutics's share price could reach $37.00 by Aug 8, 2024. The average Mineralys Therapeutics stock price prediction forecasts a potential upside of 305.26% from the current MLYS share price of $9.13.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.